0001140361-18-022037.txt : 20180507 0001140361-18-022037.hdr.sgml : 20180507 20180507173001 ACCESSION NUMBER: 0001140361-18-022037 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180507 DATE AS OF CHANGE: 20180507 EFFECTIVENESS DATE: 20180507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fountain Therapeutics, Inc. CENTRAL INDEX KEY: 0001739815 IRS NUMBER: 824181770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-311831 FILM NUMBER: 18812324 BUSINESS ADDRESS: STREET 1: 1029 CATHCART WAY CITY: STANFORD STATE: CA ZIP: 94305 BUSINESS PHONE: 650-856-1971 MAIL ADDRESS: STREET 1: 1029 CATHCART WAY CITY: STANFORD STATE: CA ZIP: 94305 D 1 primary_doc.xml X0708 D LIVE 0001739815 Fountain Therapeutics, Inc. 1029 CATHCART WAY STANFORD CA CALIFORNIA 94305 650-856-1971 DELAWARE None None Corporation true 2018 Thomas A. Rando 1029 Cathcart Way Stanford CA CALIFORNIA 94305 Executive Officer Director Promoter Mr. Rando is the President, Treasurer, Secretary of the Issuer. Biotechnology Decline to Disclose 06b false 2018-05-04 false true true Series A Preferred Stock false 0 5000000 5000000 0 false 2 0 0 0 false Fountain Therapeutics, Inc. /s/ Thomas A. Rando Thomas A. Rando President of the Issuer 2018-05-07